yao xue jin zhan

..............page:715

jing zhun yi liao shi dai de zhong liu yao li xue yan jiu
ding jian ;

..............page:721-722

yao xue jin zhan zheng ding dan

..............page:723

Tumor-associated Macrophages: Critical Role in Tumor Progression and a Potential Antitumor Target
DONG Rong;YUAN Meng;YING Meidan;CAO Ji;YANG Bo;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research;Institute of Pharmacology and Toxicology;School of Pharmaceutical Sciences;Zhejiang University;

..............page:723-733

Progress in Development of Cyclin-dependent Kinase Inhibitors as Cancer Therapy
XIE Shao;DING Jian;CHEN Yi;Division of Anti-tumor Pharmacology;State Key Laboratory of Drug Research;Shanghai Institute of Materia Medica;Chinese Academy of Sciences;

..............page:734-745

zhong guo yao xue nian jian 2014 juan zheng ding qi shi

..............page:745

Advances in Hypoxia-inducible Factor-1alpha: Moleculartargeted Therapy for Hepatocellular Carcinoma
LI Qingyu;LI Yangling;ZHANG Bo;YAN Wei;LING Nengming;Department of Clinical Pharmacy;Affiliated Hangzhou Hospital;Nanjing Medical University;Department of Clinical Pharmacology;Hangzhou Translational Medicine Research Center;Hangzhou First People’s Hospital;

..............page:746-753

yao xue jin zhan za zhi 2016 nian zheng ding qi shi

..............page:753

Research Progress of E-cadherin in Cancer Therapy
CHANG Linlin;ZHU Hong;ZHENG Lin;CAO Ji;LUO Peihua;HE Qiaojun;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research;School of Pharmaceutical Sciences;Zhejiang University;

..............page:754-760

Progress in Research of Inhibitors Targeting PARP-1 for Cancer Therapy
XIE Yiyue;SHI Tianchen;WANG Luying;XU Xiaowei;LI Yanghui;LIN Kejiang;School of Pharmacy;China Pharmaceutical University;

..............page:761-774

Research Progress in Biological Activity and Structure-activity Relationship of Limonoids
HAN Xueqing;ZHU Qihua;WANG Shaochi;XU Yungen;State Key Laboratory of Natural Medicines;China Pharmaceutical University;Department of Medical Chemistry;China Pharmaceutical University;

..............page:775-780

Progress in Clinical Transformation of Fibroblast Growth Factors and Related New Drug Development
HUI Qi;LI Xiaokun;WANG Xiaojie;Pharmacy School of Wenzhou Medical University;Key Laboratory of Biotechnology Pharmaceutical Engineering of Zhejiang Province;Zhejiang Groster Biological Technology Co.;Ltd.;

..............page:781-786

World Preview 2015,Outlook to 2020(Ⅲ)
EvaluatePharma;

..............page:787-791

Ixazomib——the First Oral Proteasome Inhibitor for Multiple Myeloma
Thomson Reuters;

..............page:792-793

An Overview of New Drugs Approved in the US and EU in October 2015
SUN Yousong;

..............page:794-800